TearLab Corporation reported preliminarily unaudited earnings guidance for the fourth quarter and full year ended December 31, 2015. The company estimates that total revenue for the quarter ended December 31, 2015 will be approximately $6.8 million, reflecting an increase of approximately 28% from the fourth quarter of 2014.

For the full year 2015, the Company anticipates total revenue to be approximately $25.2 million, representing total year-over-year revenue growth of approximately 28%.

TearLab anticipates that it will maintain a 20 plus percent year-over-year revenue growth rate in 2016. TearLab believes the combination of revenue growth, improving gross margins and disciplined cost control would allow it to achieve positive cash flow from operations when its annual revenue reaches a range of $50 million to $60 million.

TearLab concluded that it would be required under United States generally accepted accounting principles to incur an impairment charge for the fourth quarter of 2015 related to OcuHub of approximately $1.4 million related to the impairment of intangibles and fixed assets.